Nektar Therapeutics · NASDAQ:NKTR

Ajer Jeffrey Robert received 2,000 Nektar Therapeutics shares as an award (Form 4)

Traded Sep 23, 2026 · Filed Sep 25, 2026

On Sep 23, 2026, Ajer Jeffrey Robert (Director) received 2,000 Nektar Therapeutics shares as an award, leaving 4,277 shares. Filed Sep 25, 2026 (Form 4).

Awarded
2,000 shares
Holding after
4,277 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 23, 2026Common StockAward2,0004,277Direct

Source

View original at SEC

Related